JPRN-UMIN000026073
Completed
Phase 2
Randomized trial of clinical effect of 6 months or 3months Gn-RH agonist (Goserelin acetate 1.8mg) to endometriosis comlicated uterine myoma - Goserelin trial
Department of Obstetrics and Gynecology Nara Medical University0 sites80 target enrollmentFebruary 13, 2017
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Obstetrics and Gynecology Nara Medical University
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •pregnant patient severe clinical complication (ex.cancer) patients who were desired for emergent operation unknown genital bleeding
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effects of Hintonia latiflora in type 2 diabeticsMild and moderate diabetes mellitus of type II (age-related)Nutritional, Metabolic, EndocrineISRCTN83308122Gehrlicher Pharmazeutische Extrakte GmbH (Germany)40
Completed
Not Applicable
The effect of inhaled corticosteroids (ICS) on airway inflammation in chronic obstructive pulmonary disease (COPD)chronic obstructive pulmonary disease (COPD)Respiratory - Chronic obstructive pulmonary diseaseACTRN12612001111864GlaxoSmithKline's (GSK)34
Completed
Not Applicable
A randomised trial of 6 months versus 12 months withdrawal of methotrexate in patients with Juvenile Idiopathic Arthritis (JIA) in clinical remissioJuvenila Idiopathic Arthritis (JIA)Musculoskeletal DiseasesJuvenila idiopathic arthritisISRCTN18186313Pediatric Rheumatology International Trials Organisation (PRINTO) (Italy) and Wyeth Pharma300
Active, not recruiting
Not Applicable
A randomised trial of 6 months versus 12 months withdrawal of methotrexate in patiebts with juvenile idiopathic arthritis in clinical remission.Ensayo aleatorizado de retirada de Metotrexate a los 6 meses versus a los 12 meses, en pacientes con Artritis Idiopática Juvenil (AIJ) en remisión clínica - MTX withdrawal studyThe present study was designed for the follow up of two groups of patients with JIA, in whom remission was achieved using MTX. In group 1 treatment with MTX will be discontinued as early as 6 months after documentation of remission on medication. In group 2 treatment with MTX will be discontinued later than 12 mpnths after documentation of remission on medication.EUCTR2005-001086-34-ESIstituto Giannina Gaslini-PRINTO200
Active, not recruiting
Not Applicable
A randomised trial of 6 months versus 12 months withdrawal of methotrexate in patients with juvenile idiopathic arthritis in clincal remission - MTX withdrawal studyThe present study was designed for the follow up of two groups of patients with JIA, in whom remission was achieved using MTX. In group 1 treatment with MTX will be discontinued as early as 6 months after documentation of remission on medication. In group 2 treatment with MTX will be discontinued later than 12 months after documentation of remission on medicationEUCTR2005-001086-34-DKISTITUTO GIANNINA GASLINI-PRINTO200